| Time | Pre-Congress Workshop 1 Kidney transplant immunopathology |
Pre-Congress Workshop 2 Organ donation & procurement |
Pre-Congress Workshop 3 Workup of potential transplant recipients |
|
| 0815 - 0830 | Course overview Vathsala Anantharaman |
Course overview Omar Sulaiman |
Course overview Rosnawati Yahya |
|
| 0830 - 0900 | 0830 – 0915 The immune response to transplantation Minnie Sarwal
|
Active donor detection in Spain. Is there a wrong or a right way to do it? Chloe Balleste |
CKD burden in Asia Vivekanand Jha |
|
| 0900 - 0930 | 0915 – 0930 BREAK |
Ancillary testing in brain death Gene Sung |
Economics of transplantation in Asia Sunita Bavanandan |
|
| 0930 - 1000 | 0930 – 1015 Immune cells involved in transplantation rejection Lim Wai Hon |
Updates on donor maintenance to deliver quality organs for transplantation Omar Sulaiman |
Optimising potential recipients for kidney transplantation Vathsala Anantharaman |
|
| 1000 - 1030 | COFFEE BREAK | |||
| 1030 - 1100 | 1030 – 1115 Tissue typing and detection of pre-formed antibodies Melissa Yeung |
Understanding refusals: what makes family consent? Omid Ghobadi |
Surgical aspects of kidney transplant recipients Murali Sundram |
|
| 1100 - 1130 | 1115 – 1145 Induction therapy Daniel Brennan |
Challenges in family donor conversation Sumana Navin and Sujatha Suriyamoorthi |
Consensus guideline on immunological evaluation of transplant recipients Jeremy Chapman |
|
| 1130 - 1200 | 1145 – 1200 BREAK |
Managing the original kidney disease Steve Alexander |
||
| 1200 - 1230 | Desensitisation – HLA antibodies, ABOi transplantation Lim Soo Kun |
Bringing teams together, sharing experience Omar Sulaiman |
Pre-transplant cardiac evaluation Marcelo Cantarovich |
|
| 1230 - 1300 | Immunosuppressive drugs Romina Danguilan |
Normothermic machine perfusion for liver allograft Peter Friend |
Surgical aspects of liver transplant recipients Mohamed Rela |
|
| 1300 - 1400 | LUNCH | |||
| 1400 - 1430 | Renal allograft histopathology: Banff Classification Mark Haas |
HCV and HIV positive donors Dorry Segev |
Pediatric renal recipient work-up Yap Hui Kim |
Vitallink Session I Greetings from international and regional leaders Jeremy Chapman, Curie Ahn, Marcelo Cantarovich, Ghazali Ahmad, Pandaan Batchuluun, Harun Ur Rashid, Khin Maung Htay, Haphan Haian |
| 1430 - 1500 | T cell mediated rejection: diagnosis and management Kate Wyburn |
The power of social media and how it can affect organ donation Rafidah Abdullah |
What does the HLA crossmatch mean? Melissa Yeung |
Rules of organ allocation and distribution (20 minutes) Stefan Tullius |
Deceased organ donor management including DCD (20 minutes) Lee Jae Myeong |
||||
| 1500 - 1530 | 1500 – 1515 BREAK |
Organ donation and COVID-19: Clinical issues Marian Irazabal |
Frailty-assessment and prognosis Dorry Segev |
|
| Organ donation and COVID-19: World registries Maria Paula Gomez |
How to improve consent rate for deceased organ donation in hospitals? (20 minutes) Pandaan Batchuluun |
|||
| 1530 - 1600 | 1515 – 1545 Antibody mediated rejection: diagnosis and management Brian Nankivell |
i-DTI and telemedicine Estephan Arredondo Cordova |
Ethical issues in deceased organ donation and transplantation (20 minutes) Peter Stock |
|
| Artificial intelligence and robotics in organ donation Marian Irazabal |
Panel discussion (30 minutes) Speakers and advisors |
|||
| 1600 - 1630 | 1545 – 1630 Strategies for achieving tolerance Megan Sykes |
|||
| Closing comments Jeremy Chapman |
||||
| 1700 - 1830 | OPENING CEREMONY | |||
| Time | PLENARIES | |||
| 0900 - 0930 | Plenary 1: Management of transplantation in the digital era Dorry Segev |
|||
| 0930 - 1000 | Plenary 2: The challenges of prolonging kidney allograft survival Jeremy Chapman |
|||
| 1000 - 1030 | COFFEE BREAK | |||
| 1000 - 1200 | AST Council Meeting | |||
| 1030 - 1230 | STATE OF THE ART SYMPOSIUM (1) | |||
| Kidney transplant | Liver transplant | Heart & Lung | Donation & ethics | |
| 1030 - 1050 | Deceased donor kidney quality and allograft outcome Yang Jaeseok |
Epidemiology of non-alcoholic fatty liver and non-alcoholic steatohepatitis: implications for liver transplantation Dan Yock Young |
Setting up a pediatric heart transplant and MCS (mechanical circulatory support) programme David Morales |
The Declaration of Istanbul on Organ Trafficking and Transplant Tourism 2018 Mustafa al-Mousawi |
| 1050 - 1110 | Causes of death with function – what can we do to prevent it? Steve Chadban |
Role of bridging therapies in acute and acute-on-chronic liver failures Shiv Kumar Sarin |
mTOR Inhibitors in heart transplantation Azmee Ghazi |
Importance of post donation care: a comparison of practices around the world Tina Coco |
| 1110 - 1130 | What is immunological risk? Roslyn Mannon |
Emerging indications for liver transplantation James Fung |
Pulmonary hypertension and lung transplantation Allan Granville |
Malaysia: curbing illegal overseas transplantation. Should we deny recipients of free immunosuppressants? Ghazali Ahmad |
| 1130 - 1150 | Trials in kidney transplantation Jonathan Craig |
Living donor liver transplantation for acute on chronic liver failure Subhash Gupta |
Bridging to lung transplantation: who, when and with what? Hiroshi Date |
DCD – Euthanasia, withdrawal of therapy, reintubation…where do we draw the line? Chloe Balleste |
| 1150 - 1210 | Selection criteria for transplantation in HCC Kyung Suk Suh |
Opting in vs opting out: which works better? Marti Manyalich |
||
| 1210 - 1230 | ||||
| 1230 - 1400 | INDUSTRY SPONSORED LUNCH SYMPOSIUM | |||
| ABSTRACT PRESENTATIONS (selected oral presentations) |
||||
| 1400 - 1410 | ||||
| 1410 - 1420 | ||||
| 1420 - 1430 | ||||
| 1430 - 1440 | ||||
| 1440 - 1450 | ||||
| 1450 - 1500 | ||||
| 1500 - 1510 | ||||
| 1510 - 1520 | ||||
| 1520 - 1530 | ||||
| 1530 - 1540 | ||||
| 1540 - 1610 | COFFEE BREAK | |||
| 1610 - 1640 | Plenary 3: Chimerism, transplant tolerance and beyond Megan Sykes |
|||
| 1640 - 1800 | DEBATES and STATE OF THE ART SYMPOSIUM (2) | |||
| Kidney - debates | Liver - debates | Heart & Lung | Transplantation and COVID-19 | |
| 1640 - 1720 | Robotic renal transplantation vs Open renal transplantation – which is a better technique? Robotic: Pranjal Modi Open: Sandeep Guleria |
Active drinkers should be transplanted Pro: James Fung Con: Mohamed Rela |
Artificial intelligence in LVAD implantation David Morales (20 minutes) |
COVID-19: Results of the international survey Marcelo Cantarovich (20 minutes) |
| Late complications following lung transplantation Allan Glanville (20 minutes) |
||||
| 1720 - 1800 | Liver transplantation for liver metastasis Pro: Deniz Balci Con: Alfred Kow |
Living related lung transplant – Japanese model Hiroshi Date (20 minutes) |
Clinical presentation, complications, and outcomes in solid organ transplant recipients Madeleine Heldman (25 minutes) |
|
| Management of the transplant programme in the time of COVID-19 Hiroto Egawa (25 minutes) |
||||
| Time | PLENARIES AND REGISTRIES | |||
| 0800 - 0830 | Plenary 4: Liver transplantation in metastatic liver disease Deniz Balci |
|||
| 0830 - 0900 | Plenary 5: 50 donors p.m.p. is not a dream anymore: how did Spain do it? Marti Manyalich |
|||
| 0900 - 1000 | Asian transplantation registries for collaboration and harmony 0900-0915: What can we learn from registries? Jeong Jong Cheol 0915-0930: Setting up an Asian registry for COVID-19 Terence Kee 0930-0945: Setting up an Asian registry for transplantation tourism Toby Coates 0945-1000: Improving harmony among registries Kenji Yuzawa |
|||
| 1000 - 1030 | COFFEE BREAK | |||
| 1030 - 1230 | STATE OF THE ART SYMPOSIUM (3) | |||
| Kidney | Liver | Donor and procurement | Surgical aspects of kidney transplantation | |
| 1030 - 1050 | T cell mediated rejection Sundaram Hariharan |
Current trends of immunosuppression in liver transplantation James Fung |
Organ donation innovative strategy in South East Asia (ODISSeA): what have we learnt? Muhammad Iqbal Abdul Hafiz |
The complex living donor Mustafa al-Mousawi |
| 1050 - 1110 | Management of ABMR: Current updates Kate Wyburn |
Acute liver failure and transplantation – indicators for poor outcome Subhash Gupta |
Deceased donation. should we allow donor family to meet recipients? Tina Coco |
The complex recipient Clarence Lei |
| 1110 - 1130 | Paired kidney exchange: success and challenges and lesson learnt Vivek Kute |
ABO incompatible liver transplantation Albert Chan |
Overcoming cultural barriers: is this the key to gaining consent? Katy Najafizadeh |
Role of interventional radiologist in kidney transplantation Basri Johan |
| 1130 - 1150 | ABO incompatible renal transplantation Kazunari Tanabe |
Role of Interventional radiology post liver transplant Basri Johan |
Increasing demand on master education for donation & transplantation. Marti Manyalich |
Coping with donor complications Sandeep Guleria |
| 1150 - 1210 | Burnout amongst donor coordinators: is it real? Sumana Navin |
When should I not proceed with kidney transplantation from a surgical perspective? Anant Kumar |
||
| 1210 - 1230 | ||||
| 1230 - 1400 | INDUSTRY SPONSORED LUNCH SYMPOSIUM | |||
| 1400 - 1600 | STATE OF THE ART SYMPOSIUM (4) | |||
| Transplant immunology | Surgical aspects of liver transplantation | Transplant infectious disease | Biomarkers in transplantation | |
| 1400 - 1420 | High resolution HLA typing in solid organ transplantation: is it necessary? Melissa Yeung |
Advances in surgical techniques in living donor liver transplantation Deniz Balci |
Asymptomatic bacteriuria post kidney transplantation: what to do Angela Webster |
Biomarkers in acute rejection Manikkam Suthanthiran |
| 1420 - 1440 | HLA mismatching and kidney transplant outcomes: what matters? Lim Wai Hon |
Laparoscopic living donor hepatectomy: safety and efficacy Alfred Kow |
Unusual infections from deceased donors Mustafa al-Mousawi |
Biomarkers in chronic allograft dysfunction Minnie Sarwal |
| 1440 - 1500 | Denovo DSA: risk factors and clinical consequences Kate Wyburn |
Long term liver transplant outcomes Albert Chan |
Difficult fungal infections: diagnostic approaches and management Vivek Kute |
Gut microbiome in solid organ transplantation Steve Chadban |
| 1500 - 1520 | Clinical relevance of non-HLA antibodies Minnie Sarwal |
Organ preservation Glenn Bonney |
Latent TB: detection and management Vivekanand Jha |
|
| 1520 - 1540 | Pediatric liver transplantation Mohamed Rela |
Respiratory viral infections in transplant recipients Atul Humar |
||
| 1540 - 1550 | ||||
| 1550 - 1620 | COFFEE BREAK | |||
| 1620 - 1800 | STATE OF THE ART SYMPOSIUM (5) | |||
| Kidney | Women in transplantation | Transplant immunology | Post-transplant complications | |
| 1620 - 1640 | Belatacept in kidney transplant: past and future perspectives Lionel Rostaing |
Equity in donors and recipients in places with disparities Vathsala Anantharaman |
Eplet matching in kidney transplantation Lim Wai Hon |
Transplant-associated thrombotic microangiopathy - more than just clot and bleed Masaomi Nangaku |
| 1640 - 1700 | Optimising mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention Wong Hin Seng |
Equity in leadership Germaine Wong |
Role of DSA monitoring post kidney transplantation Christophe Legendre |
Post-transplant lymphoproliferative disorders Atul Humar |
| 1700 - 1720 | Can mTORi be combined with CNI in renal transplantation? Experimental and clinical evidence Yang Chul Woo |
Fertility and pregnancy post solid organ transplantation Maggie Ma |
The influence of immunosuppressive agents on the risk of denovo DSA in solid organ transplant recipients Lionel Rostaing |
Risk of cancer after solid organ transplant in childhood Jonathan Craig |
| 1720 - 1740 | Evolution of Banff Classification: 20 years ahead Brian Nankivell |
How women can bring change to organ transplantation - the Mongolian experience Lkhaakhuu Od-Erdene |
The role for inhibition of the CD40-CD154 pathway in co-stimulation blockade Lionel Rostaing |
Obesity and metabolic syndrome post transplantation: prevention and management Kim Yeong Hoon |
| 1740 - 1800 |
MicroRNA profiles predictive of organ allograft status
Manikkam Suthanthiran |
|||
| 1800 - 1810 | ||||
| Time | PLENARIES | |||
| 0830 - 0900 | Plenary 6: Experimental xenotransplantation Megan Sykes |
|||
| 0900 - 1000 | STATE OF THE ART SYMPOSIUM (6) | |||
| Innovation in transplantation | Post-transplant complications | Asian experts in Transplantation | Women in transplantation | |
| 0900 - 0920 | Clinical transplantation: how do we measure performance? Steve Chadban |
Current strategies in post-transplant diabetes mellitus Masaomi Nangaku |
Translational research in transplantation Hideki Ohdan |
Gender balance in living donation - from the recipient's and donor's perspective
Allison Tong (15 minutes) Nicole Scholes-Robertson (15 minutes) Amanda Dominello (15 minutes) |
| 0920 - 0940 | Future of research in transplantation Jeremy Chapman |
Bone disease post transplantation: spectrum, impact, prevention and management Wong Jiunn |
Sex disparities in access to transplantation care during COVID-19 in Asia Yong-Guang Yang |
|
| 0940 - 1000 | Role of macrophages in transplant oncology and immunology Nancy Kwan Man |
Sex disparities in access to transplantation care during COVID-19 in Asia Vasanthi Ramesh (20 minutes) |
||
| 1000 - 1030 | COFFEE BREAK | Pregnancy induced sensitisation and sex disparity in living donation Deirdre Sawinski (20 minutes) |
||
| Panel discussion (30 minutes) Speakers and WIT members |
||||
| 1030 - 1230 | ABSTRACT PRESENTATIONS (selected oral presentations) |
Vitallink Session II How to improve self-sufficiency in Asia? |
||
| 1030 - 1040 | Introduction Activity of deceased organ transplantation in Asia Jeong Jong Cheol (20 minutes) |
|||
| 1040 - 1050 | Vietnam Haphan Haian (10 minutes) |
|||
| 1050 - 1100 | Myanmar Khin Maung Htay (10 minutes) |
|||
| 1100 - 1110 | Bangladesh Harun Ur Rashid (10 minutes) |
|||
| 1110 - 1120 | Indonesia Atma Gunawan (10 minutes) |
|||
| 1120 - 1130 | Sri Lanka Ruwan Dissanayake (10 minutes) |
|||
| 1130 - 1140 | ||||
| 1140 - 1150 | Nepal Dibya Singh (10 minutes) |
|||
| 1150 - 1200 | ||||
| 1200 - 1210 | Ejaz Ahmed (10 minutes) |
|||
| 1210 - 1220 | Mongolia Pandaan Batchuluun (10 minutes) |
|||
| 1220 - 1230 | Review and comments: How to achieve self-sufficiency in Asia? Marcelo Cantarovich (20 minutes) |
|||
| 1230 - 1330 | AST General Body Meeting | |||
| 1230 - 1400 | INDUSTRY SPONSORED LUNCH SYMPOSIUM | |||
| 1400 - 1510 | STATE OF THE ART SYMPOSIUM (7) and ROUNDTABLES | |||
| Transplantation in Asia – challenges & way forward | Transplant infectious diseases |
The ODISSeA project (Malaysia, Thailand, Myanmar, Philippines) Maria Gomez Koong Jun Kit Muhammad Iqbal Chatchai Mingmalairak Htar Kyi Swe Khin Thida Thwin Maria Bad-Ang Stephanie Andres |
||
| 1400 - 1420 | Role of Vitallink in advancing transplantation in Asia Curie Ahn |
CMV: Consensus on monitoring, prevention, and therapeutic updates Atul Humar |
||
| 1420 - 1440 | Longest on waiting list vs fittest and shortest waiting time gets the kidney Rosnawati Yahya |
COVID-19: Vaccination in transplant recipients Dorry Segev |
||
| 1440 - 1500 | The Spanish model: can it be implemented in Asia? Chloe Balleste |
Hepatitis C: When is the optimal time to treat? Tan Soek Siam |
||
| 1500 - 1510 | ||||
| 1515 - 1600 | CLOSING CEREMONY & AWARDS CEREMONY | |||
(Updates as 31 March 2021)